Skip to main content

Table 3 Background characteristics of the study participants at commencement of HAART, total and sex segregated

From: Trends in prevalence of selected opportunistic infections associated with HIV/AIDS in Uganda

Characteristic

Total (N = 1741)

Female (N = 1413)

Male (N = 328)

p-value*

Age in years, median (IQR)

44(37,50)

43(37,49)

45(40,52)

0.001

WHO stage III & IV, n (%)

1113(63.9)

929(65.7)

184(56.1)

0.121

CD4 cells/μl, median (IQR) (2005–6)

128(55,190)

144(65,191)

49(39,92)

0.074

ART regime (2005–2013), n (%)

    

  d4T + 3TC+ NVP

693(40)

638(45)

136(41)

0.233

  ZDV +3TC + NPV

774(44)

562(40)

131(40)

  other

274(16)

213(15)

61(19)

  1. Key: *Chi2-Test; IQR = Interquartile range; ART = Antiretroviral therapy; d4T = Stavudine; 3TC = Lamivudine, NVP = Nevirapine; ZDV = Zidovudine, WHO = World Health Organisation.